| 
												  
													
														   
													       
															Technical Problem and Solution 
											          C.  Bio-Nano Synthesis Using SPL Techniques for Biotechnology Applications: 
													         
The industrial biotechnology  standards for genomic and proteomic assays require parallel fluid delivery and  experimental testing of 48, 96, 384 or a higher number of unique chemical  species. The fluid handling for these operations is usually achieved by a robotic  fluid dispenser. For the SPL process to be scaled to the required industrial  standards - larger numbers of unique species need to be delivered than are  possible by current Inkwell™ devices. However, increasing the throughput of the  number of inks creates challenges for fluid metering, delivery, the spatial  real-estate on the device and the spatial addressing of the chemical species  while compromising reliability and cross-contamination issues. Also, the  minimum fluid volume dispensing capabilities of the commercial robotic  dispensers are limited to about 1 ml  (micro-liter). The SPL process typically requires fluid dispensing volume of  100 pico-liters or less, which is about 10,000 times smaller than the  capability of the current robotic dispensers. This makes the SPL technique more  challenging and also more attractive due to the significant material savings of  costly reagents, probes, primers and analytes used in the assays. 
											           
													        
                                                              
                                                                | The  proposed study (Figure 6) involves a scheme for synthesizing biological  materials (oligonucleotides, peptides, etc.) and maximizing the throughput of  the number of inks to conform to the industrial standard of 96 (or higher) for  DPN applications in biotechnology.  | 
                                                                  | 
                                                               
                                                              
                                                                The scheme consists of the design,  fabrication of microfluidic devices with integrated micro-coolers, and  environmental control system. The proposed scheme obviates the need for fluid  metering devices, pumping mechanisms and spatial addressing issues and their  associated complications. The microfluidic device proposed here consists of a  two-dimensional array of micro-wells formed on a substrate. The micro-wells  will be integrated with commercially available micro-coolers (thermo-electric  coolers, Peltier devices). Micro-beads of hygroscopic material such as PEG  (Poly-Ethylene-Glycol) which are available commercially18 can be dispensed into  the micro-wells to create a bead-array co-located with the  micro-well array. The microfluidic device will be positioned in the DPN stage  housed in the environmental chamber. By controlling temperature ramp-up and  ramp-down cycles of the micro-coolers and the environmental control apparatus  to below the dew-point it is possible to condense water droplets on the PEG  beads. The hygroscopic property of the PEG solutions will ensure that the  microwells do not dry out by spontaneous evaporation. Commercially available  PEG beads pre-mixed with customized functional molecules of interest (genomic  species or proteins/peptides) can also be used. The micro-beads are  commercially available in various sizes ranging from 1-1000 microns18.  Following the formation of PEG solution in the microwell array – the pen  apparatus will be dipped into the microwells for loading inks and subsequent  bio-nanolithography steps using multiple inks. This will enable the creation of  nano-bio-arrays (gene chips, protein chips, etc.) with substantial scaling in  biological information content on these devices. 
                                                                    The work involves designing proper environmental control  schemes and temperature ramp-cycles of the microfluidic apparatus. The effect  of PEG micro-bead sizes on nucleation and condensation will also be studied.  The experiments will be optimized for the material synthesis and lithography  steps. The deposited biological materials will be characterized by lateral  force microscopy and their biological activity will be characterized by  performing appropriate assays.
                                                                     
 | 
                                                               
                                                             
													           
													        
													          | 
													 | 
													 |